| Market Cap | 347M 305M 283M 260M 489M 33.42B 496M 3.37B 1.32B 16.43B 1.3B 1.27B 56.81B | P/E 2026 * |
38.1x | P/E 2027 * | 10.6x |
|---|---|---|---|---|---|
| Enterprise Value | 347M 305M 283M 260M 489M 33.42B 496M 3.37B 1.32B 16.43B 1.3B 1.27B 56.81B | EV / Sales 2026 * |
4.97x | EV / Sales 2027 * | 3.45x |
| Free-Float |
81.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fennec Pharmaceuticals Inc
| 1 day | +1.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeffrey Hackman
CEO | Chief Executive Officer | 64 | 2024-08-15 |
Robert Andrade
DFI | Director of Finance/CFO | 51 | 2010-01-05 |
Pierre Sayad
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 72 | 2011-08-24 |
Khalid Islam
CHM | Chairman | 69 | 2015-12-08 |
Marco Brughera
BRD | Director/Board Member | 70 | 2016-08-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.29% | +3.66% | - | - | 347M | |
| +0.86% | +1.43% | +47.17% | +161.40% | 1,067B | |
| +1.59% | +4.09% | +56.51% | +52.79% | 635B | |
| +0.95% | +1.91% | +36.30% | +83.13% | 458B | |
| +1.60% | +6.25% | +37.00% | +30.00% | 347B | |
| -0.60% | +1.52% | +36.67% | +39.80% | 295B | |
| -0.14% | +0.60% | +17.29% | +18.19% | 262B | |
| +0.09% | -2.82% | -29.09% | -41.29% | 216B | |
| +1.22% | +2.66% | +22.66% | +59.81% | 203B | |
| -1.18% | -3.70% | +11.28% | +67.43% | 161B | |
| Average | +0.57% | +1.33% | +26.20% | +52.36% | 404.83B | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +78.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 69.83M 61.33M 57.03M 52.34M 98.33M 6.72B 99.85M 677M 265M 3.31B 262M 256M 11.43B | 100M 88.22M 82.04M 75.29M 141M 9.67B 144M 974M 381M 4.76B 377M 369M 16.44B |
| Net income | 8.99M 7.9M 7.34M 6.74M 12.66M 866M 12.86M 87.19M 34.07M 426M 33.75M 33.02M 1.47B | 33.1M 29.07M 27.04M 24.81M 46.61M 3.19B 47.33M 321M 125M 1.57B 124M 122M 5.42B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
